Evidence map›Paper›PMID 24879872›Full record

ArticleThe Journal of physiology2014

Direct excitation of parvalbumin-positive interneurons by M1 muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition.

Feng Yi, Jackson Ball, Kurt E Stoll, Vaishali C Satpute, Samantha M Mitchell, Jordan L Pauli, Benjamin B Holloway, April D Johnston, Neil M Nathanson, Karl Deisseroth and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 121 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Targeting muscarinic receptors for treating schizophrenia.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Article
  6. Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. The potential of muscarinic MFrontiers in psychiatry · 2024
    Review
  18. Review
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Feng YiCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
Jackson BallCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
Kurt E StollCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
Vaishali C SatputeCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences Neuroscience Graduate Program.
Samantha M MitchellCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences Davidson Honors College, The University of Montana, Missoula, MT 59812, USA.
Jordan L PauliCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
Benjamin B HollowayCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
April D JohnstonCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences.
Neil M NathansonDepartment of Pharmacology, University of Washington, Box 357750, Seattle, WA 98195-7750, USA.
Karl DeisserothDepartment of Bioengineering, Stanford University, Stanford, CA, USA.
David J GerberHoward Hughes Medical Institute, RIKEN-MIT Neuroscience Research Center, The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Susumu TonegawaHoward Hughes Medical Institute, RIKEN-MIT Neuroscience Research Center, The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
J Josh LawrenceCOBRE Center for Structural and Functional Neuroscience Department of Biomedical and Pharmaceutical Sciences josh.lawrence@umontana.edu.
Howard Hughes Medical Institute · USStanford University · USUniversity of Montana · USUniversity of Washington · US

Funding

Differential modes of cholinergic transmission onto cellular hippocampal targetsR01NS069689 · NINDS · UNIVERSITY OF MONTANA · PI LAWRENCE, JOHN JOSHUA · 2010 to 2014
$1.5M
Store-operated calcium channels in neuropathic painR21NS077330 · NINDS · DREXEL UNIVERSITY · PI HU, HUIJUAN · 2012 to 2013
$418k
NINDS NIH HHS R01 NS069689NINDS NIH HHS R21 NS077330-01A1.
6 · The paper itself

Abstract

Parvalbumin-containing (PV) neurons, a major class of GABAergic interneurons, are essential circuit elements of learning networks. As levels of acetylcholine rise during active learning tasks, PV neurons become increasingly engaged in network dynamics. Conversely, impairment of either cholinergic or PV interneuron function induces learning deficits. Here, we examined PV interneurons in hippocampus (HC) and prefrontal cortex (PFC) and their modulation by muscarinic acetylcholine receptors (mAChRs). HC PV cells, visualized by crossing PV-CRE mice with Rosa26YFP mice, were anatomically identified as basket cells and PV bistratified cells in the stratum pyramidale; in stratum oriens, HC PV cells were electrophysiologically distinct from somatostatin-containing cells. With glutamatergic transmission pharmacologically blocked, mAChR activation enhanced PV cell excitability in both CA1 HC and PFC; however, CA1 HC PV cells exhibited a stronger postsynaptic depolarization than PFC PV cells. To delete M1 mAChRs genetically from PV interneurons, we created PV-M1 knockout mice by crossing PV-CRE and floxed M1 mice. The elimination of M1 mAChRs from PV cells diminished M1 mAChR immunoreactivity and muscarinic excitation of HC PV cells. Selective cholinergic activation of HC PV interneurons using Designer Receptors Exclusively Activated by Designer Drugs technology enhanced the frequency and amplitude of inhibitory synaptic currents in CA1 pyramidal cells. Finally, relative to wild-type controls, PV-M1 knockout mice exhibited impaired novel object recognition and, to a lesser extent, impaired spatial working memory, but reference memory remained intact. Therefore, the direct activation of M1 mAChRs on PV cells contributes to some forms of learning and memory.

Indexed as

Action PotentialsCognitionInhibitory Postsynaptic PotentialsAnimalsCA1 Region, HippocampalFemaleInterneuronsMaleMiceParvalbuminsPrefrontal CortexReceptor, Muscarinic M1ParvalbuminsReceptor, Muscarinic M1

Identifiers

PMID24879872
PMCPMC4229343
OpenAlexW1602026523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.